🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well nivolumab and ipilimumab immunotherapy w...
Status
Suspended
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2024-02-19
Trial ID
NCT05904080
This phase II trial studies the side effects and how well low dose ipilimum...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2019-02-21
Trial ID
NCT03873818
Treatments Being Tested
This phase I trial studies the safety and best dose of ipilimumab, nivoluma...
Status
Completed
Location
UCSF Medical Center-Parnassus
Start Date
2015-04-16
Trial ID
NCT02311920
Treatments Being Tested
This phase II/III trial studies the side effects of nivolumab and ipilimuma...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-11-23
Trial ID
NCT02339571
This phase II trial studies the effect of immunotherapy drugs (ipilimumab a...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-12-24
Trial ID
NCT04145115
Treatments Being Tested
This phase I trial tests the safety and effectiveness of nivolumab and ipil...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-23
Trial ID
NCT07128680
This phase I trial studies the side effects and best doses of cabozantinib ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2015-07-22
Trial ID
NCT02496208
This phase III trial compares the effect of immunotherapy (IO) with stereot...
Status
Recruiting
Location
Alta Bates Summit Medical Center-Herrick Campus
Start Date
2026-02-26
Trial ID
NCT07166406
This phase II trial tests whether nivolumab and ipilimumab works to shrink ...
Status
Terminated
Location
University of Alabama- Birmingham
Start Date
2023-01-19
Trial ID
NCT05199285
Treatments Being Tested
This phase II trial studies how well nivolumab with or without ipilimumab w...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2015-05-13
Trial ID
NCT02314169
Treatments Being Tested